This molecule inhibited rat C6 glioma cell proliferation and migration in vitro and inhibited tumor growth in vivo, favoring the notion that selective inhibition of PTPRZ1 may be a promising therapeutic approach in GBM [119]. The gene discussed is PTPRZ1; the disease is central nervous system cancer.